Dr. Sharon Mannheimer has been the site leader of ICAP’s Harlem Prevention Center since its inception over a decade ago. She is a practicing board-certified Infectious disease physician with over twenty years of experience and expertise in HIV/AIDS treatment and prevention. Most of her career has been in Harlem where she provides clinical care and conducts clinical research, including HIV prevention studies of oral pre-exposure prophylaxis (PrEP), long-acting injectable PrEP, broadly neutralizing monoclonal antibodies, and an HIV vaccine. In addition, she has served as a protocol team member and currently serves as protocol co-chair of HVTN 130/HPTN 089, a combination monoclonal antibody trial for HIV prevention. Recently her research has shifted to also include COVID-19 and overseeing the implementation of vaccine and monoclonal antibody trials for COVID-19 prevention.